Daré Bioscience, Inc. [NASDAQ:DARE], a clinical-stage, women's biopharmaceutical company, today announced that it has entered into an agreement with Orbis Biosciences, Inc. for the development of an injectable etonogestrel contraceptive with 6- and 12 ...
more»